Gender dependence for a subset of the low-abundance signaling proteome in human platelets

Human Genomics and Proteomics

Volumn , Issue , 2010, Pages

  Pollard, Harvey B ^a   Eidelman, Ofer ^a   Jozwik, Catherine ^a   Huang, Wei ^a   Srivastava, Meera ^a   Rothwell, Stephen W ^a   Jacobowitz, David M ^b   Ji, Xiaoduo ^a   Zhang, Xiuying ^a   Guggino, William ^c   Wright, Jerry ^c   Kiefer, Jeffrey ^d   Olsen, Cara ^a   Adimi, Nima ^a   Mueller, Gregory P ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTEGRIN; CASPASE 7; I KAPPA B ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROSTACYCLIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; STAT3 PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEGAKARYOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEOMICS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 77953412766     PISSN: None     EISSN: 17574242     Source Type: Journal    
DOI: 10.4061/2010/164906     Document Type: Article

References (82)

1. Awtry E. H., Loscalzo J., Aspirin Circulation 2000 101 10 1206 1218
2. Quinn M. J., Fitzgerald D. J., Ticlopidine and clopidogrel Circulation 1999 100 15 1667 1672
3. Agnelli G., Rationale for the use of platelet aggregation inhibitors in PAD patients Vascular Medicine 2001 6 3 13 15
4. Aronow W. S., Antiplatelet therapy in peripheral arterial disease Current Drug Targets: Cardiovascular and Haematological Disorders 2004 4 3 265 267
5. Tendera M. B., Wojakowski W., Role of antiplatelet drugs in the prevention of cardiovascular events Thrombosis Research 2003 110 5-6 355 359
6. Tran H., Anand S. S., Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease Journal of the American Medical Association 2004 292 15 1867 1874
7. Grau A. J., Reiners S., Lichy C., Buggle F., Ruf A., Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study Stroke 2003 34 4 849 854
8. Ferroni P., Basili S., Davi G., Platelet activation, inflammatory mediators and hypercholesterolemia Current vascular pharmacology 2003 1 2 157 169
9. Pathansali R., Smith N., Bath P., Altered megakaryocyteplatelet haemostatic axis in hypercholesterolaemia Platelets 2001 12 5 292 297
10. Collier A., Tymkewycz P. M., Matthews D. M., Jones R. L., Clarke B. F., Changes in some aspects of platelet function with improvement of glycaemic control over 6 months Diabetes Research 1987 5 2 79 82
11. Tschope D., Langer E., Schauseil S., Rosen P., Kaufmann L., Gries F. A., Increased platelet volumesign of impaired thrombopoiesis in diabetes mellitus Klinische Wochenschrift 1989 67 4 253 259
12. Papanas N., Symeonidis G., Maltezos E., Mean platelet volume in patients with type 2 diabetes mellitus Platelets 2004 15 8 475 478
13. Smith N. M., Pathansali R., Bath P. M. W., Platelets and stroke Vascular Medicine 1999 4 3 165 172
14. Greisenegger S., Endler G., Hsieh K., Tentschert S., Mannhalter C., Lalouschek W., Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004 35 7 1688 1691
15. Nadar S. K., Blann A. D., Kamath S., Beevers D. G., Lip G. Y. H., Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Journal of the American College of Cardiology 2004 44 2 415 422
16. Pathansali R., Smith N. M., Bath P. M. W., Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study Platelets 2001 12 3 144 149
17. Bath P. M. W., Butterworth R. J., Platelet size: measurement, physiology and vascular disease Blood Coagulation and Fibrinolysis 1996 7 2 157 161
18. Desideri G., Simone M., Iughetti L., Early activation of vascular endothelial cells and platelets in obese children Journal of Clinical Endocrinology and Metabolism 2005 90 6 3145 3152
19. Laws A., Hoen H. M., Selby J. V., Saad M. F., Haffner S. M., Howard B. V., Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status: relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 1 64 71
20. Srivastava M., Eidelman O., Jozwik C., Serum proteomic signature for cystic fibrosis using an antibody microarray platform Molecular Genetics and Metabolism 2006 87 4 303 310
21. Pollard H. B., Srivastava M., Eidelman O., Protein microarray platforms for clinical proteomics Proteomics: Clinical Applications 2007 1 9 934 952
22. Radomski M. W., Palmer R. M., Moncada S., The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide British Journal of Pharmacology 1987 92 3 639 646
23. White J. G., Electron microscopy methods for studying platelet structure and function Methods in Molecular Biology 2004 272 47 63
24. Pollard H. B., Ji X.-D., Jozwik C., Jacobowitz D. M., High abundance protein profiling of cystic fibrosis lung epithelial cells Proteomics 2005 5 8 2210 2226
25. Pollard H. B., Eidelman O., Jozwik C., De Novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells Molecular and Cellular Proteomics 2006 5 9 1628 1637
26. Tusher V. G., Tibshirani R., Chu G., Significance analysis of microarrays applied to the ionizing radiation response Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5116 5121
27. Eidelman O., Srivastava M., Zhang J., Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-α R/NF B pathway Molecular Medicine 2001 7 8 523 534
28. Srivastava M., Eidelman O., Zhang J., Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from fibrosis lung epithelial cells Proceedings of the National Academy of Sciences of the United States of America 2004 101 20 7693 7698
29. Nagata Y., Nagahisa H., Nagasawa T., Todokoro K., Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells Leukemia 1997 11 supplement 3 435 438
30. Kirito K., Osawa M., Morita H., A functional role of Stat3 in in vivo megakaryopoiesis Blood 2002 99 9 3220 3227
31. Vassilev A. O., Lorenz D. R., Tibbles H. E., Uckun F. M., Role of the leukemia-associated transcription factor STAT3 in platelet physiology Leukemia and Lymphoma 2002 43 7 1461 1467
32. Chui C. M. Y., Li K., Yang M., Chuen C. K. Y., Fok T. F., Li C. K., Yuen P. M. P., Platelet-derived growth factor up-regulates the expression of transcription factors NF-E2, GATA-1 and c-Fos in megakaryocytic cell lines Cytokine 2003 21 2 51 64
33. Liu X.-L., Yuan J.-Y., Zhang J.-W., Zhang X.-H., Wang R.-X., Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage Journal of Leukocyte Biology 2007 82 4 986 1002
34. Sun S., Zimmet J. M., Toselli P., Thompson A., Jackson C. W., Ravid K., Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes Haematologica 2001 86 1 17 23
35. Rubiolo C., Piazzolla D., Meissl K., A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation Blood 2006 108 1 152 159
36. Bassini A., Pierpaoli S., Falcieri E., Selective modulation of the cyclin B/CDK1 and cyclin D/CDK4 complexes during in vitro human megakaryocyte development British Journal of Haematology 1999 104 4 820 828
37. Vitrat N., Cohen-Solal K., Pique C., Endomitosis of human megakaryocytes are due to abortive mitosis Blood 1998 91 10 3711 3723
38. Ozawa Y., Towatari M., Tsuzuki S., Histone deacetylase 3 associates with and represses the transcription factor GATA-2 Blood 2001 98 7 2116 2123
39. Nagata Y., Nishida E., Todokoro K., Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3 Blood 1997 89 8 2664 2669
40. Zhang C., Gadue P., Scott E., Atchison M., Poncz M., Activation of the megakaryocyte-specific gene protein (PBP) by the Ets family factor PU.1 Journal of Biological Chemistry 1997 272 42 26236 26246
41. Chanprasert S., Geddis A. E., Barroga C., Fox N. E., Kaushansky K., Thrombopoietin (TPO) induces c-myc expression through a PI3K-and MAPK-dependent pathway that is not mediated by Akt, PKC or mTOR in TPO-dependent cell lines and primary megakaryocytes Cellular Signalling 2006 18 8 1212 1218
42. Vignais M.-L., Gilman M., Distinct mechanisms of activation of Stat1 and Stat3 by platelet-derived growth factor receptor in a cell-free system Molecular and Cellular Biology 1999 19 5 3727 3735
43. Burstein S. A., Effects of interleukin 6 on megakaryocytes and on canine platelet function Stem Cells 1994 12 4 386 393
44. Yeh H.-H., Lai W.-W., Chen H. H. W., Liu H.-S., Su W.-C., Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion Oncogene 2006 25 31 4300 4309
45. Herrmann A., Vogt M., Mnnigmann M., Nucleocytoplasmic shuttling of persistently activated STAT3 Journal of Cell Science 2007 120 18 3249 3261
46. Azim A. C., Barkalow K., Chou J., Hartwig J. H., Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor Blood 2000 95 3 959 964
47. Bahou W. F., Michelson A. D., Thrombin receptors Platelets 2007 2nd Elsevier/Academic Press 179 200
48. Elrod J. W., Park J. H., Oshima T., Sharp C. D., Minagar A., Alexander J. S., Expression of junctional proteins in human platelets Platelets 2003 14 4 247 251
49. Halama T., Groger M., Pillinger M., Platelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functions Journal of Investigative Dermatology 2001 116 1 110 117
50. Kim S. D., Lee I.-K., Lee W. M., The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase European Journal of Pharmacology 2008 584 2-3 361 367
51. Pan C.-F., Shen M.-Y., Wu C.-J., Hsiao G., Chou D.-S., Sheu J.-R., Inhibitory mechanisms of gabapentin, an antiseizure drug, on platelet aggregation Journal of Pharmacy and Pharmacology 2007 59 9 1255 1261
52. 2+ entry by protein kinase C Journal of Biological Chemistry 1995 270 41 23887 23890
53. Buensuceso C. S., Obergfell A., Soriani A., Regulation of outside-in signaling in platelets by integrin-associated protein kinase C Journal of Biological Chemistry 2005 280 1 644 653
54. Kojima H., Shinagawa A., Shimizu S., Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function Experimental Hematology 2001 29 5 616 622
55. Baldassare J. J., Henderson P. A., Burns D., Loomis C., Fisher G. J., Translocation of protein kinase C isozymes in thrombin-stimulated human platelets: correlation with 1,2-diacylglycerol levels Journal of Biological Chemistry 1992 267 22 15585 15590
56. Tate B. F., Rittenhouse S. E., Thrombin activation of human platelets causes tyrosine phosphorylation of PLC-2 Biochimica et Biophysica Acta 1993 1178 3 281 285
57. Li J., Kuter D. J., The end is just the beginning: megakaryocyte apoptosis and platelet release International Journal of Hematology 2001 74 4 365 374
58. Kaluzhny Y., Ravid K., Role of apoptotic processes in platelet biogenesis Acta Haematologica 2004 111 1-2 67 77
59. De Botton S., Sabri S., Daugas E., Platelet formation is the consequence of caspase activation within megakaryocytes Blood 2002 100 4 1310 1317
60. Caraveo G., van Rossum D. B., Patterson R. L., Snyder S. H., Desiderio S., Action of TFII-I outside the nucleus as an inhibitor of agonist-induced calcium entry Science 2006 314 5796 122 125
61. Coste A., Antal M. C., Chan S., Absence of the steroid receptor coactivator-3 induces B-cell lymphoma The EMBO Journal 2006 25 11 2453 2464
62. Thompson A., Zhang Y., Kamen D., Jackson C. W., Cardiff R. D., Ravid K., Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization Journal of Biological Chemistry 1996 271 38 22976 22982
63. Hackzell A., Uramoto H., Izumi H., Kohno K., Funa K., p73 independent of c-Myc represses transcription of platelet-derived growth factor-receptor through interaction with NF-Y Journal of Biological Chemistry 2002 277 42 39769 39776
64. Fuhrken P. G., Apostolidis P. A., Lindsey S., Miller W. M., Papoutsakis E. T., Tumor suppressor protein p53 regulates megakaryocytic polyploidization and apoptosis Journal of Biological Chemistry 2008 283 23 15589 15600
65. Song L.-N., Cheng T., Glucocorticoid-induced growth inhibition and differentiation of a human megakaryoblastic leukemia cell line: involvement of glucocorticoid receptor Stem Cells 1993 11 4 312 318
66. + T cells suppress autologous megakaryocyte apoptosis in idiopathic thrombocytopenic purpura British Journal of Haematology 2007 139 4 605 611
67. Ezumi Y., Shindoh K., Tsuji M., Takayama H., Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor chain complex on human platelets Journal of Experimental Medicine 1998 188 2 267 276
68. Jackson D. E., Ward C. M., Wang R., Newman P. J., The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. Evidence for a mechanistic link between PECAM-1-and integrin-mediated cellular signaling Journal of Biological Chemistry 1997 272 11 6986 6993
69. Edmead C. E., Crosby D. A., Southcott M., Poole A. W., Thrombin-induced association of SHP-2 with multiple tyrosine-phosphorylated proteins in human platelets FEBS Letters 1999 459 1 27 32
70. Hua C. T., Gamble J. R., Vadas M. A., Jackson D. E., Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1): identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates Journal of Biological Chemistry 1998 273 43 28332 28340
71. Li D., August S., Woulfe D. S., GSK3 is a negative regulator of platelet function and thrombosis Blood 2008 111 7 3522 3530
72. Liu F., Morris S. A., Epps J. L., Carroll R. C., Demonstration of an activation regulated NF-κB/I-B complex in human platelets Thrombosis Research 2002 106 4-5 199 203
73. Escolar G., Bastida E., Garrido M., Sex-related differences in the effects of aspirin on the interaction of platelets with subendothelium Thrombosis Research 1986 44 6 837 847
74. Lawrence J. B., Leifer D. W., Moura G. L., Sex differences in platelet adherence to subendothelium: relationship to platelet function tests and hematologic variables American Journal of the Medical Sciences 1995 309 4 201 207
75. Kurrelmeyer K., Becker L., Becker D., Yanek L., Goldschmidt-Clermont P., Bray P. F., Platelet hyperreactivity in women from families with premature atherosclerosis Journal of the American Medical Womens Association 2003 58 4 272 277
76. Bord S., Frith E., Ireland D. C., Scott M. A., Craig J. I. O., Compston J. E., Estrogen stimulates differentiation of megakaryocytes and modulates their expression of estrogen receptors and Journal of Cellular Biochemistry 2004 92 2 249 257
77. Nagata Y., Yoshikawa J., Hashimoto A., Yamamoto M., Payne A. H., Todokoro K., Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol Genes and Development 2003 17 23 2864 2869
78. Fox S. W., Chambers T. J., The effect of oestrogen on megakaryocyte differentiation and platelet counts in vivo International Journal of Cardiology 2006 109 3 359 366
79. Jayachandran M., Okano H., Chatrath R., Owen W. G., McConnell J. P., Miller V. M., Sex-specific changes in platelet aggregation and secretion with sexual maturity in pigs Journal of Applied Physiology 2004 97 4 1445 1452
80. ONeill E. E., Brock C. J., von Kriegsheim A. F., Towards complete analysis of the platelet proteome Proteomics 2002 2 3 288 305
81. Maguire P. B., Fitzgerald D. J., Platelet proteomics Journal of Thrombosis and Haemostasis 2003 1 7 1593 1601
82. Marcus K., Moebius J., Meyer H. E., Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets Analytical and Bioanalytical Chemistry 2003 376 7 973 993